biopharma partnerships
therapeutic programs initiated
clinical programs initiated
commercial products and BLAs filed
Our proprietary yeast-based antibody discovery platform combines fully human synthetic and immune libraries to enable delivery of highly specific, stable, and developable IgGs, HCAbs, and multispecifics.
From target to preclinical lead, our integrated process includes antigen acquisition, high-throughput library sorting, in-depth hit characterization, and precision engineering to produce therapeutic antibodies efficiently and reliably.
Access high-quality synthetic and immune libraries delivering therapeutic antibodies for the clinic.
Transform leads into high-affinity, developable candidates through guided engineering and real-time screening.
Engineer multispecifics, including T-cell engagers, of diverse formats for function, manufacturability, and scalability.
Leverage AI-guided engineering of non-antibody proteins for tailored binding, stability, and expression.
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s,"
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s,"
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s,"
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s,"
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s,"
Adimab is built to support your goals. With no internal pipeline, we are fully aligned with our partners, offering flexible collaboration models and a complete suite of antibody discovery and engineering capabilities tailored to your program’s needs.
Leverage Adimab’s proprietary platform to discover antibody leads that we transfer to you to move into the clinic.
Gain full access to our antibody discovery and optimization platform to drive programs in your own facility.
Access proprietary, proven modules—our TCE and heterodimer technologies are already trusted by 20+ partners.
